Navigation Links
Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
Date:4/7/2009

- New offices in Chile and Peru, expansion of Argentina office increase access to patients to reduce drug development timelines for biopharmaceutical companies -

PRINCETON, N.J., April 7 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced the recent opening of new clinical development offices in Santiago, Chile, and Lima, Peru, and the expansion of the company's Buenos Aires, Argentina office. These latest office openings further extend the company's global clinical development presence to increase patient access and reduce clinical development timelines.

Covance has been providing clinical trial support in Latin America since 1997 with the company's first office in Buenos Aires, Argentina. Operations in Latin America expanded quickly with the organization of an extensive and highly-trained network of regional clinical trial monitors. The new clinical offices located in Santiago and Lima will support staff in Chile and Peru, including Covance's regional network of field-based clinical research associates throughout Latin America.

"Our strategy is to target areas for qualified patient populations and the most qualified investigators as we selectively expand our presence in key metropolitan centers in emerging regions such as Latin America," said Katie Margules, Covance's senior director of project management in Latin America. "Our focus continues to be on delivering outstanding drug development and building stronger strategic relationships with our clients."

The new offices and expanded facilities in Latin America will help Covance expedite the execution of clinical studies with a full range of services, and build strategic relationships with investigators, sites, and regulatory authorities in a region known for its strong potential to contribut
'/>"/>

SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
2. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
3. Covance Purchases Equity Stake in Caprion Proteomics
4. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
5. Covance Decides to Pursue Its Original Preclinical Strategy in China
6. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
7. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
8. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
10. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
11. Cells Exhibition Opens at Maryland Science Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 21, 2014 Why did Stephen Hawking ... Einstein so instantly recognizable? Why have they become icons ... and author Hilton Ratcliffe seeks out the answers to ... all to do with science. In " Stephen Hawking ... November 21, 2014), Ratcliffe puts it plainly: , ...
(Date:11/21/2014)... , Nov. 20, 2014  Cytori Therapeutics (NASDAQ: ... Hedrick , M.D. will present live at VirtualInvestorConferences.com on December ... TIME:    11:15 am PT / 2:15 pm ET ... into your browser,s address bar: http://bit.ly/1B2KGaL ... receive event updates. This will be a ...
(Date:11/18/2014)... Urdorf, Switzerland (PRWEB) November 17, 2014 ... range of processes across the pharmaceutical, chemical, and food ... is it so important, and how do pH sensors ... measurement to assist those in process industries with these ... description of pH measurement in the process industries. The ...
(Date:11/18/2014)... November 18, 2014 2014 ... Industry is professional and in-depth report on ... basic information, including its definition, characterization, application, ... outline. This exploration covers the worldwide business ... industry examination covering macroeconomic environment & financial ...
Breaking Biology Technology:“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 2Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 4pH Guide from METTLER TOLEDO Explains Measurement, Theory and Practice of pH Applications 2PTMEG Market: 2019 Global Polytetrahydrofuran Industry Development Trends & Analysis Now at DeepResearchReports.com 2PTMEG Market: 2019 Global Polytetrahydrofuran Industry Development Trends & Analysis Now at DeepResearchReports.com 3
... South Korean scientists have succeeded in engineering the bacterium ... research, published in the journal Biotechnology and Bioengineering ... this important chemical which is traditionally created using fossil ... is an important platform chemical with a wide range ...
... - Net Profit Up 11%, - Strong Research and Investment Effort, - Positive net ... 25 August 2009 under the chairmanship,of Albert Saporta approved the 2009 half year financial statements: , , In million Euros ... ... %CA, Sales ...
... , , SAN MARINO, ... company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, ... releases distributed by collegestock.com on August 25 and August 26, and ... Reader Grapevine: There,s Something About Viral Genetics, Inc. (VRAL)," on August ...
Cached Biology Technology:Pioneering research succeeds in producing industrially vital chemical through engineered bacteria 2STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 2STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 3STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 4Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases 2Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases 3
(Date:11/6/2014)... an asset for a predator. Except when that predator runs ... beetle, relative to its size, is the fastest creature on ... lengths per second (at about five miles per hour). The ... the sprinting gold from the tiger beetle, a person would ... tiger beetle has a problem. At peak speeds, everything becomes ...
(Date:11/5/2014)... in the UTSA College of Sciences, is one ... receive a two-year $300,00 National Science Foundation (NSF) ... funding supports President Obama,s BRAIN Initiative, a federal ... that will demystify complex brain processes. , ... broken into the interactions of multiple components, each ...
(Date:11/5/2014)... diversity in their ability to identify scents and odors. ... their perceptual evaluation of odors, with women outperforming men ... Sex differences in olfactory detection may play a role ... one,s perception of smell, which is naturally linked to ... been suggested to be cognitive or emotional, rather than ...
Breaking Biology News(10 mins):The tiger beetle: Too fast to see 2UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3The female nose always knows: Do women have more olfactory neurons? 2
... will not only teach us more about the way neurons ... diagnostics and therapies for neurological diseases such as Parkinson,s," says ... take a major toll on society. More than 8% of ... cent suffers from a mental disturbance and the number of ...
... is now leading to breakthroughs in bio nanotechnology research. ... reality. Four years ago, the biologist Karen ... when she started with her team working on it, ... at the Nano-Science Center, her team has been able ...
... the first time, the successful reprogramming of diseased human ... also found differentiation into mature hepatocytes was more efficient ... diseased hepatocyte-derived human iPSC lines provides a good basis ... technology could give a potentially unlimited reservoir of cells ...
Cached Biology News:Skywalker ensures optimal communication between neurons 2From science fiction to research breakthrough 2
... Description: Proteinase K is a ... wide range of applications purified from the fungus ... the carboxyl group of N-substituted hydrophobic aliphatic and ... as a serine protease. Proteinase K is useful ...
... high throughput, water bath thermal cycler capable of ... This equates to 9,216 reactions per run when ... transfers a basket of plates between three water ... considerably faster than those of peltier block cyclers. ...
... Dideoxycytidine Dideoxycytidine is a cytidine analog that ... retroviral activity. Immunogen: Chemical / ... The specificity of the ddC antiserum was ... of ddC to moles of ddC analog at ...
... The Jouan MSC series of Class ... working conditions and certification to the ... regulation ensures that the cabinets cannot ... conditions. Natural lighting, low noise and ...
Biology Products: